---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-026054"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-08-29T23:59:59+00:00"
generated_at: "2026-05-17T09:22:04.042045+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Enveric Biosciences files 8-K for investor presentation; no specific facts in filing

## Summary
- Management will release a Q3 2025 investor presentation on the company's website on or about Aug 29, 2025.
- Presentation may be used with investors, analysts, lenders, and business partners.
- No financial or operational details from the presentation are included in the filing.

## SEC filing metadata
- accession: 0001641172-25-026054
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-08-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000164117225026054/0001641172-25-026054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000164117225026054/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-026054
- JSON: https://secwatch.observer/filing/0001641172-25-026054.json
- Plain text: https://secwatch.observer/filing/0001641172-25-026054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.